Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO) multicenter trial.
David E KandzariDimitri KarmpaliotisAnnapoorna S KiniJeffrey W MosesPradyumna E TummalaJ Aaron GranthamCharles OrrWilliam LombardiWilliam J NicholsonNicholas J LemboJeffrey J PopmaJin WangWeiying ZhaoRobert McGreevyPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
In a multicenter registration trial representing contemporary technique and EES, these results demonstrate sustained long-term safety and effectiveness of EES in CTO percutaneous revascularization and can be used to inform shared decision making with patients being considered for CTO PCI relative to late safety and vessel patency.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- end stage renal disease
- randomized controlled trial
- coronary artery bypass grafting
- coronary artery
- study protocol
- systematic review
- clinical trial
- phase iii
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- newly diagnosed
- phase ii
- acute coronary syndrome
- cross sectional
- preterm infants
- atrial fibrillation
- aortic stenosis
- prognostic factors
- heart failure
- st segment elevation myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- ultrasound guided
- double blind
- patient reported outcomes
- open label
- radiofrequency ablation
- transcatheter aortic valve replacement
- patient reported